Cite
MLA Citation
Scott M. Hynes et al.. “Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patients.” Biopharmaceutics & drug disposition, vol. 36, n.d., pp. 49–63. http://access.bl.uk/ark:/81055/vdc_100025016468.0x000033